App-Quantinova.ai

International Comparison of Patient Characteristics and Performance Measures in Acute Ischemic Stroke: Analysis of the American Heart Association Get With the Guidelines-Stroke Registry and China National Stroke Registry

Zixiao Li - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Heart Failure is Associated With Elevated von Willebrand Factor (vWF) Antigen but not Factor VIII (FVIII) in Acute Ischemic Stroke (AIS)

Karen Albright - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

FVIII

Coated-platelets Levels After Subarachnoid Hemorrhage Predict Post-discharge Short-term Cognitive Outcome

Vijay M Pandav - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Which is a Better Predictor of Functional Outcome, TICI Score or Perfusion Imaging?

Michael Mlynash - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Thrombophilia Risk Factors in Perinatal Stroke: 213 Consecutive Cases

Jeanette Beaute - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Plaque Inflammation Imaging in Carotid Stenosis and Recurrent Cerebral Ischemia

Amit Kulkarni - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

Assessment and Provision of Rehabilitation Among Acute Ischemic Stroke Patients Hospitalized in China: Findings From the China National Stroke Registry II

Janet Prvu Bettger - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Prognosis of Cerebral Venous Thrombosis and Provoking Risk Factors

Sang-Mi Noh - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Transverse Sinus Hypoplasia as a Predisposing Factor for Cerebral Venous Thrombosis

Miguel Barboza - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Mutagenesis Studies Revealed Minimal Impact of Human A120T Variant of Protease-activated Receptor 4 on Receptor function or Pharmacological Response to a Potent and Selective Antagonist

Jeffrey Colin - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Evithrom

Plasma Kallikrein Inhibition Reduces Tissue Plasminogen Activator-induced Stroke Damage and Hemorrhage Transformation

Allen C. Clermont - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

The Impact of Intracardiac Thrombi on Recurrent Ischemic Events in Acute Ischemic Stroke Patients With Non-valvular Atrial Fibrillation the Samurai-nvaf Study

Hiroshi Yamagami - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Incidence, Risk Factors, and In-Hospital Outcomes Associated With Hospital-Acquired Conditions and Patient Safety Indicators In Spontaneous Intracerebral Hemorrhage

Ashna Rajan - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

DVT Prophylaxis in Intracerebral Hemorrhage Patients in a Large Health System: a 5 Year Analysis

Tamela Stuchiner - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Heparin

Differential Alternative Splicing of Leukocyte mRNAs After Intracerebral Hemorrhage and Ischemic Stroke of Different Etiologies

Glen C Jickling - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Nitric oxide

Assessing Quality of Patient Care in Pediatric Stroke Hospitalizations: An Analysis of the Nationwide Inpatient Sample

Adithi Reddy - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Anatomical Venous Variants and Physiological Adaptive Changes in Children With Cerebral Sinovenous Thrombosis

Andrea Andrade - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Prothrombotic Role of Platelet Tlr2 in Hyperlipidemia

Liang Xin - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Platelet 12-lipoxygenase is a Key Regulator of Platelet Reactivity and Thrombus Formation in vivo

Katherine Mast - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Early Elevation of D-dimer Values Is Associated With Neurological Deterioration in Acute Ischemic Stroke due to Cerebral Artery Dissection

Masafumi Ihara - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Filters

7277 Abstracts